Key Takeaways & Executive Findings
- •• • Wild-type KLF7 overexpression significantly increased NF-κB reporter activity in Ishikawa, HeLa, and EC109 cells (P < 0.05), whereas deletion of any single zinc finger (D1, D2, or D3) abolished this enhancement (P < 0.05), demonstrating that all three zinc fingers are required for inflammatory pathway activation. • • KLF7 did not alter NFKB1 mRNA (P > 0.05) or RelA (P65) protein levels in any cell line, indicating that its pro-inflammatory action occurs downstream of NFKB1 gene expression, which matters clinically because targeting KLF7 zinc fingers could modulate downstream cytokine production without disrupting core NF-κB component synthesis. • • Wild-type KLF7 significantly increased promoter activities of ACADL, ECH1, and HADHB (P < 0.05) in all three cell types, while zinc-finger-deficient mutants failed to do so, establishing that zinc fingers are essential for transcriptional control of fatty acid β-oxidation genes and highlighting a potential therapeutic vulnerability in metabolic disorders. • • Western blot analysis with ACTB as internal control confirmed that wild-type KLF7 elevated CPT1A, ACADL, and ECH1 protein expression, whereas zinc-finger deletions abrogated these increases, providing translational evidence that KLF7 zinc fingers are required for both transcriptional and protein-level regulation of β-oxidation, with implications for insulin resistance and obesity.
China Biomedical & Cell Therapy Radar
Get verified English translations, SEM micrographs & open-access PDF alerts from China's leading state key laboratories delivered to your inbox every Monday at 08:00 EST.
Abstract
Krüppel-like factor 7 (KLF7) is a C2H2 zinc-finger transcriptional regulator implicated in insulin resistance, inflammation, and fatty acid metabolism. The functional necessity of its three zinc fingers for human KLF7 activity remained undefined. We engineered pCMV-myc-KLF7_WT and three zinc-finger deletion mutants (D1, D2, D3) and expressed them in HEK293T, Ishikawa, HeLa, and EC109 cells. Western blot confirmed expected Myc-tagged protein sizes at 48 h. Luciferase reporter assays showed that wild-type KLF7 significantly increased NF-κB activity (P < 0.05) and the promoter activities of ACADL, ECH1, and HADHB (P < 0.05) across all three cell lines, whereas deletion of any single zinc finger abolished these effects (P < 0.05). KLF7 did not alter NFKB1 mRNA (P > 0.05) or RelA (P65) protein levels, indicating downstream action within the NF-κB cascade. For fatty acid β-oxidation, wild-type KLF7 elevated CPT1A, ACADL, and ECH1 promoter activities and protein expression, with ACTB as internal control; zinc-finger-deficient mutants failed to sustain these transcriptional and translational increases. These data establish that the zinc-finger domain is indispensable for KLF7-mediated enhancement of NF-κB signaling and fatty acid β-oxidation gene transcription in human cells, providing a mechanistic basis for targeting KLF7 zinc fingers in metabolic and inflammatory disorders.
1. Introduction
Krüppel-like factor 7 (KLF7) regulates insulin secretion, adipogenesis, and inflammatory signaling, yet the structural determinants of its transcriptional activity in human cells have remained poorly defined. Prior work in chicken preadipocytes indicated that deletion of the third zinc finger impairs KLF7 function, but whether this finding extends to human KLF7 and to its dual roles in NF-κB signaling and fatty acid β-oxidation was unknown. This gap is clinically relevant because KLF7 aggravates metabolic disorders and promotes proinflammatory cytokine production, and no targeted inhibitor of KLF7 exists. Without a precise mapping of zinc-finger requirements, efforts to develop small molecules or biologics that disrupt KLF7–DNA interactions lack a validated structural target.
To address this bottleneck, we engineered wild-type KLF7 and three zinc-finger deletion mutants (D1, D2, D3) in pCMV-myc vectors and expressed them in HEK293T, Ishikawa, HeLa, and EC109 cells. We then quantified NF-κB reporter activity, NFKB1 mRNA, RelA (P65) protein, and the promoter activities and protein levels of CPT1A, ACADL, ECH1, and HADHB. This systematic deletion analysis directly tests whether individual zinc fingers are necessary for KLF7-mediated transcription, providing the first human cell-based evidence that the zinc-finger domain is indispensable for both inflammatory and metabolic gene regulation.
Loading authentic research manuscript (Pages 1–5)...
TIAN Jiazhen, ZHANG Tingting, QI Zhaoxiong, CHEN Yuechan, MI Xiangquan, ZHANG Zhiwei (2025). Zinc Fingers Are Responsible for the Efficient Control of KLF7 on the Transcription of Genes in the NF-κB Signaling Pathway and Fatty Acid β-Oxidation. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025053
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioDataare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the quantitative impact of zinc-finger deletion on KLF7-mediated NF-κB activation, and does it vary across cell lines?
In Ishikawa, HeLa, and EC109 cells, wild-type KLF7 significantly increased NF-κB reporter activity compared to empty vector (P < 0.05). All three zinc-finger deletion mutants (D1, D2, D3) failed to enhance NF-κB activity, with no significant difference from empty vector (P > 0.05). The effect was consistent across all three cell lines, indicating that the zinc-finger requirement is not cell-type-specific.
Does KLF7 regulate NFKB1 mRNA or RelA (P65) protein levels, and what does this imply for downstream inflammatory targets?
KLF7 overexpression did not significantly alter NFKB1 mRNA expression (P > 0.05) or RelA (P65) protein levels in Ishikawa, HeLa, or EC109 cells. This indicates that KLF7 acts downstream of NFKB1 gene expression, likely by modulating the activity of NF-κB complexes rather than their abundance. Clinically, this suggests that KLF7 inhibitors would not suppress core NF-κB component synthesis but could attenuate downstream proinflammatory cytokine production.
Which fatty acid β-oxidation genes are transcriptionally regulated by KLF7, and what is the role of zinc fingers in this regulation?
Wild-type KLF7 significantly increased the promoter activities of ACADL, ECH1, and HADHB (P < 0.05) in all three cell lines. It also elevated CPT1A, ACADL, and ECH1 protein levels as shown by western blot with ACTB as internal control. Zinc-finger deletion mutants abolished these increases, demonstrating that the zinc-finger domain is required for KLF7 to enhance fatty acid β-oxidation gene transcription and translation.
What are the translational implications of these findings for targeting KLF7 in metabolic and inflammatory diseases?
The data establish that all three zinc fingers are necessary for KLF7 to enhance NF-κB signaling and fatty acid β-oxidation gene expression. This provides a validated structural target for small-molecule or biologic inhibitors designed to disrupt KLF7–DNA binding. Such inhibitors could simultaneously dampen inflammation and improve lipid metabolism, offering a dual therapeutic strategy for insulin resistance, obesity, and related cardiovascular complications.
What are the limitations of this study regarding in vivo validation and clinical translation?
This study was conducted in HEK293T, Ishikawa, HeLa, and EC109 cell lines using overexpression systems, which may not fully replicate endogenous KLF7 regulation in primary tissues. No in vivo animal models or human clinical samples were tested. The absence of dose-response data for KLF7 expression and the lack of rescue experiments with zinc-finger add-back mutants limit the mechanistic depth. Future work should validate these findings in animal models of metabolic syndrome and assess the druggability of the zinc-finger domain.
Related Chinese Research & Cross-Citations
miR-199a-3p suppresses Vldlr expression to promote cardiomyocyte proliferation
The proliferative capacity of cardiomyocytes is limited in adult mammals, and replacing lost tissue following acute ischemic injury is challenging. Previous studies have demonstrated that miR-199a-3p can promote cardiomyocyte proliferation, but the exact mechanism by which this occurs remains unclear, although multiple targets of miR-199a-3p have been identified. We recently showed that very-low-density-lipoprotein receptor (Vldlr) inhibits cardiomyocyte proliferation, and in this study we aim to test whether Vldlr is a functional target gene of miR-199a-3p. 3′UTR reporter assays demonstrate that miR-199a-3p directly binds to the 3′UTR of Vldlr and inhibits its translation. Overexpressing Vldlr blunts the pro-proliferative effect of miR-199a-3p on cardiomyocytes, suggesting that Vldlr is indeed a functional target of miR-199a-3p. Mechanistically, Vldlr reduces S807/811 phosphorylation of RB1, and inhibiting CDK4/6 to prevent RB1 phosphorylation can block the pro-proliferative effect of both Vldlr knockdown and miR-199a-3p, suggesting that RB1 phosphorylation is required for the cardiomyocyte proliferation induced by miR-199a-3p and Vldlr knockdown. The findings of this study reveal Vldlr as a novel functional target of miR-199a-3p in cardiomyocytes and identify RB1 as a downstream effector of cardiomyocyte proliferation. The identification of the role of the miR-199a-3p-Vldlr-RB1 axis in cardiomyocyte proliferation may provide potential therapeutic targets for cardiac regenerative medicine.
A positive feedback loop between FOSB and miR-133b controls colon cancer cell proliferation
FOSB, a member of the FOS gene family, forms heterodimers with JUN family proteins to engage in diverse cellular processes. Its biological impacts vary among different types of tumors, yet its specific function in colon cancer (CC) remains ambiguous. In this study, quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC) are applied to measure FOSB expression levels, followed by an analysis of the association between FOSB expression and patients’ clinical parameters. In vitro experiments are performed to assess cell proliferation, including growth rate, cell cycle distribution, and apoptosis. A subcutaneous xenograft model in nude mice is utilized to monitor tumor growth in vivo. Additionally, chromatin immunoprecipitation (ChIP) and luciferase reporter assays are conducted to dissect the interactions among FOSB, miR-133b, and POU2F1. The results indicate that FOSB expression is downregulated in CC tissues relative to normal controls. Overexpression of FOSB suppresses proliferation and promotes apoptosis in CC cells. Mechanistically, FOSB binds to the promoter region of miR-133b, enhancing its transcription and subsequently repressing POU2F1 expression. Notably, decreased POU2F1 expression also alleviates the transcriptional repression of the FOSB promoter region, establishing a FOSB-miR-133b-POU2F1 feedback loop that inhibits CC proliferation. In summary, our findings suggest that FOSB acts as a tumor suppressor gene in CC and may exert its inhibitory effects on CC growth via the FOSB-miR-133b-POU2F1 feedback loop.
A protein-RNA complex orchestrated by EMB1006, EMB1270, EMB976, and CFM2 facilitates clpP1 intron 2 splicing in Arabidopsis chloroplasts
In Arabidopsis, the PPR proteins EMB1006, EMB1270, and EMB976 are all essential for the splicing of plastid clpP1 intron 2 (clpP1.2), although each also targets other distinct RNAs. The precise mechanism underlying their co-ordinated action in clpP1.2 splicing remains unclear. In this study, RNA electrophoretic mobility shift assays, guided by PPR code prediction, confirm that EMB1006 specifically binds to a sequence near the 3′ end of clpP1 exon 2. Additionally, immunoprecipitation coupled with mass spectrometry reveals that EMB1006 forms a complex with EMB1270, EMB976, and CFM2. Direct interactions between EMB1006 and EMB1270 or CFM2 are further supported by yeast two-hybrid (Y2H) and semi-in vivo pull-down assays. However, no direct interactions between EMB976 and EMB1006, CFM2 or EMB1270 are detected by Y2H. Based on these findings and previous evidence that EMB1270 binds to clpP1 intron 2 and interacts with CFM2, we propose a model in which EMB1006 and EMB1270 bind to distinct sites on clpP1 pre-mRNA. Together with CFM2 and possible indirect association with EMB976, they assemble into a protein-RNA complex that facilitates the splicing of clpP1.2 in chloroplasts.
Tanshinones from Salvia miltiorrhiza alleviate ulcerative colitis via reprogramming the gut microbiota-metabolite axis
The anti-inflammatory properties of the traditional herb Salvia miltiorrhiza Bunge are well-established, yet its precise mechanism of action in ulcerative colitis (UC) remains unclear. Herein, we evaluate the therapeutic potential of four major tanshinones–tanshinone IIA (Tan IIA), miltirone, neocryptotanshinone, and dihydrotanshinone I–in a murine dextran sulfate sodium (DSS)-induced colitis model. Our results show that tanshinones effectively alleviate disease severity, suppress systemic and local inflammation, and restore intestinal barrier integrity. Integrated multi-omics analysis reveals that the therapeutic efficacy originates from a comprehensive reprogramming of the gut microbiota-metabolite axis. Specifically, tanshinones reverse colitis-associated dysbiosis and rectify metabolic disturbances in linoleic acid metabolism, bile acid biosynthesis, and amino acid utilization. Correlation network analysis identifies key functional modules linking beneficial microbes (e.g., Akkermansia) to anti-inflammatory lipid mediators and associating pathobionts (e.g., Desulfovibrio) with disrupted bile acid metabolism. Notably, supplementation with Akkermansia muciniphila synergizes with Tan IIA to amplify barrier restoration and metabolic normalization. Our findings establish that tanshinones ameliorate UC through microbiota-driven metabolic reprogramming, wherein the restructured microbial community actively shapes a therapeutic metabolic output. This work elucidates a metabolite-mediated mechanism of action and positions tanshinones as promising microbiome-targeting therapeutics for inflammatory bowel disease.
Distinct miR319a identified from Persicaria chinensis mediates cross-kingdom suppression of cervical cancer by targeting ITGA3
Persicaria chinensis, a well-known traditional Chinese medicinal herb that is both edible and medicinal, has been widely acknowledged for its therapeutic effects, such as anti-inflammatory, antioxidant, and antitumor activities. However, the role of miRNAs from this plant in the cross-kingdom regulation of human diseases has not been investigated. In this study, we analyze the miRNA expression profile of P. chinensis using high-throughput sequencing and identify a total of 673 miRNAs, including 422 novel miRNAs that are unique to this plant and 251 conserved miRNAs. Among the conserved miRNAs, pch-miR319a is found to be the most abundant. Moreover, food-oriented pch-miR319a accumulates in the uterus and tumors and exhibits a rich repertoire of target genes within cancer-related pathways, demonstrating significant cross-kingdom regulatory potential. Utilizing the dual-luciferase reporter gene assay, we demonstrate that pch-miR319a from P. chinensis targets the Itga3 gene, which is associated with cervical cancer progression. Overexpression of pch-miR319a significantly decreases the viability, migration, and induces apoptosis of HeLa cervical cancer cells in vitro. Moreover, in a syngeneic mouse tumor model of cervical cancer, treatment with pch-miR319a effectively inhibits tumor growth and downregulates the expressions of ITGA3 and the proliferation marker Ki-67. Our study highlights the potential of pch-miR319a from P. chinensis as a novel therapeutic agent for cervical cancer by targeting ITGA3 and provides new insights into the cross-kingdom regulatory mechanisms of plant miRNAs in human diseases.
Development of an in vitro TurboID labeling assay for the detection of protoRAG-interacting proteins in the amphioxus
The recombination-activating gene (RAG)-mediated V(D)J rearrangement mechanism is essential for generating the diversity of the adaptive immune system in jawed vertebrates. The RAG1 and RAG2 proteins form a tetrameric complex that recognizes and cleaves pairs of recombination signal sequences (RSSs). In jawed vertebrates, the N-terminal region of RAG1 and the C-terminal region of RAG2 are critical for the regulation of physiological function and enhancement of recombination accuracy. Moreover, the intracellular activity of RAG1/2 is rigorously regulated and is thought to represent the aspect shaped by host coevolution. However, these regulatory mechanisms remain incompletely understood, impeding our deeper understanding of the physiological functions of RAG. Previous studies have shown that jawed vertebrate RAG evolved from invertebrate RAG-like (RAGL) transposases and underwent key structural changes during evolution. RAGL genes have been identified in multiple invertebrate species, but from Branchiostoma belcheri (Bb), the RAG-like protein in Bb amphioxus (BbRAG1L) and the RAG2-like protein in Bb amphioxus (BbRAG2L) are among the most extensively characterized to date. Lancelets (amphioxus) represent the most basal extant chordates (cephalochordates) that diverged from the other two chordate lineages (urochordates and vertebrates). Consequently, amphioxus has been considered a “living fossil” for studying the origins and evolution of adaptive immunity. Homologs of the core structural domain of RAG1 were discovered in the amphioxus genome in 2005, and the homologs were subsequently shown to exhibit recombinase activity in cooperation with murine-derived RAG2. A large number of transposon genes were then identified in the amphioxus genome, followed by the identification of target site duplication (TSD) and terminal inverted repeat (TIR) sequences in the amphioxus genome. Notably, BbRAG2L lacks the C-terminal region present in murine RAG2, including the acidic hinge and PHD domain. BbRAG1L coupled with BbRAG2L displays significant transposition activity in vitro and in human cell lines. In contrast, vertebrate RAG exhibits limited transposon activity in vitro and extremely low transposon activity in vivo. This leads to the question of how RAG lost its transposase activity during evolution. Structural comparison and functional experiments of BbRAGL (protoRAG) and vertebrate RAG have revealed that vertebrates undergo essential adaptive changes to eliminate the primitive transposase activity of protoRAG. Research on BbRAGL has therefore provided strong support for the hypothesis that RAG originated from a domesticated transposon. Given the similarity in both structure and function between BbRAG1L and vertebrate RAG and the fact that BbRAGL proteins are the only RAGL proteins that can currently be efficiently expressed in vertebrate cells, characterizing the binding partners of BbRAGL involved in amphioxus is of great significance for understanding the regulation of BbRAGL and its adaptation and evolution. Parallel comparison of BbRAGL and RAG interaction networks may further clarify how BbRAGL transitioned from a transposase to a recombinase during host coevolution and reveal general principles of vertebrate intracellular RAG regulation. In recent years, proximity labeling techniques have greatly facilitated approaches to identifying RAG cofactors. For example, RAG1 fused to biotin ligase RAG1 fused to a biotin ligase found in Escherichia coli (BirM) has been used to define dynamic interaction networks of RAG-associated proteins. Inspired by these advances, we sought to apply a similar approach to identify the BbRAGL cofactors in amphioxus and build a regulatory network of BbRAGL that could shed light on its relationship with host evolution. However, endogenous BbRAGL expression is undetectable in the adult amphioxus (data not shown), and the generation of transgenic amphioxus lines expressing proximity-based labeling proteins remains technically challenging. These constraints make it difficult to analyze native cofactors of endogenous BbRAGL in vivo. Because BbRAGL can be expressed in vertebrate cell lines, we instead developed an in vitro proximity-labeling strategy. We fused TurboID (TbID), an engineered biotin ligase, to the N-terminus of BbRAG1L or BbRAG2L (Figure 1A), purified the fusion proteins, and incubated them with protein lysates prepared from the hepatic cecum and colons of adult B. belcheri amphioxus in vitro to label the interacting proteins. The proteins were finally analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) (Figure 1B). A pTT5 vector was used to express plasmids encoding maltose-binding protein (MBP) and TurboID with or without full-length BbRAG1L or BbRAG2L, yielding pTT5-MBP-TurboID, pTT5-MBP-TurboID-BbRAG1L, and pTT5-MBP-TurboID-BbRAG2L. Plasmids expressing MBP-BbRAG1L and MBP-BbRAG2L were also generated.